advanced search
Fanny Sellier
Vice-President, Strategic Marketing & Alliance Management
Biocorp

Is this your profile?

About

Fanny Sellier is Vice-President, Strategic Marketing & Alliance Management at Biocorp, with responsibility for managing collaborations with its key partners as a main focus. She joined the company in 2021. Having graduated from the ISEG business school in Strasbourg (France) and Instituts Universitaires de Technologie (IUT) de Chimie (chemical sciences), Ms Sellier worked at Rhodia (now Solvay), in the US, for seven years in marketing, lean enterprise and business development. She was then with BASF in a marketing position managing products for the home care industry. She also spent eight years with Nemera in charge of ophthalmic products, promoting the company’s preservative-free technology.

Contributions

INTERVIEW
Interview with Arnaud Guillet & Fanny Sellier
Arnaud Guillet and Fanny Sellier talk with Guy Furness about how Biocorp has become a key player in the field of connected drug delivery, discuss the current landscape for connectivity in drug delivery and update us on its two major parenteral products – Mallya and Injay – as well as looking forward to the launch of the company’s next generation of connected drug delivery solutions.

More contributions

OCULAR
USER TESTING: CRITICAL FOR TRULY UNDERSTANDING PATIENT NEEDS
Fanny Sellier presents a trio of comparative user studies between Nemera’s Novelia® preservative-free, multidose eyedropper and similar products from competitors
INTERVIEW
FANNY SELLIER, NEMERA
Talking here with ONDrugDelivery Magazine, Ms Sellier discusses Nemera’s multidose eyedropper system Novelia® for preservative-free formulations. She explains how this platform has been developed to improve patients’ lives.
OCULAR
USING INTELLIGENT DESIGN TO DELIVER SAFE MULTI-DOSE EYE DROPS
Ms Fanny Sellier, explains how the intelligent design of multi-dose bottles provides a viable means of delivering safe, preservative-free eye drops.
Top